2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Common Stock Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Weighted Average Number Of Diluted Shares Outstanding | 231.25 | NA | 125.70 | 64.24 | 63.26 | |
Weighted Average Number Of Shares Outstanding Basic | 231.25 | NA | 125.70 | 64.24 | 63.26 | |
Earnings Per Share Basic | -0.10 | 0.92 | -0.93 | -0.38 | -0.28 | |
Earnings Per Share Diluted | -0.10 | 0.92 | -0.93 | -0.38 | -0.28 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Revenues | 3.41 | 3.60 | 4.75 | 2.40 | 4.71 | |
Operating Expenses | 27.74 | 19.85 | 21.00 | 25.78 | 21.27 | |
Research And Development Expense | 20.66 | 12.68 | 11.79 | 19.79 | 12.51 | |
General And Administrative Expense | 7.08 | 6.72 | 8.59 | 5.99 | 8.75 | |
Operating Income Loss | -24.33 | -16.25 | -16.25 | -23.38 | -16.56 | |
Interest Expense | 0.03 | 0.71 | 1.47 | 1.44 | 1.37 | |
Interest Expense Long Term Debt | 1.30 | 0.70 | 1.40 | 1.40 | 1.30 | |
Interest Paid Net | 1.33 | 1.29 | 1.27 | 1.27 | 1.12 | |
Interest Income Expense Nonoperating Net | 1.69 | 1.92 | 1.11 | 0.22 | 0.32 | |
Allocated Share Based Compensation Expense | NA | 1.97 | 2.04 | 2.22 | 1.68 | |
Profit Loss | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 | |
Net Income Loss | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 | |
Net Income Loss Available To Common Stockholders Basic | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Assets | 153.00 | 172.73 | 195.77 | 81.54 | 101.60 | |
Liabilities | 99.15 | 97.79 | 244.88 | 118.66 | 116.55 | |
Liabilities And Stockholders Equity | 153.00 | 172.73 | 195.77 | 81.54 | 101.60 | |
Stockholders Equity | 53.85 | 74.94 | -49.11 | -37.11 | -14.95 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Assets Current | 130.60 | 149.87 | 171.81 | 54.12 | 72.36 | |
Cash And Cash Equivalents At Carrying Value | 123.98 | 143.94 | 164.28 | 45.08 | 63.42 | |
Other Assets Current | 0.15 | 0.29 | 0.40 | 0.51 | 0.53 | |
Prepaid Expense And Other Assets Current | 4.17 | 3.48 | 5.53 | 9.03 | 8.93 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 14.00 | 13.80 | 13.81 | 16.45 | 16.61 | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 3.31 | 2.98 | 2.64 | 2.31 | 1.97 | |
Property Plant And Equipment Net | 10.69 | 10.83 | 11.17 | 14.14 | 14.64 | |
Other Assets Noncurrent | 0.30 | 0.30 | 0.30 | 0.30 | 1.32 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Liabilities Current | 38.64 | 36.76 | 180.45 | 50.64 | 54.45 | |
Accounts Payable Current | 10.38 | 6.37 | 7.52 | 10.77 | 9.00 | |
Other Accrued Liabilities Current | 0.78 | 0.72 | 0.68 | 0.68 | 0.69 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Long Term Debt Noncurrent | 40.51 | 40.51 | 38.55 | 38.35 | 38.16 | |
Other Liabilities Noncurrent | 1.50 | 1.58 | 3.83 | 3.92 | 4.00 | |
Operating Lease Liability Noncurrent | 18.50 | 18.95 | 19.10 | 19.53 | 19.93 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Stockholders Equity | 53.85 | 74.94 | -49.11 | -37.11 | -14.95 | |
Common Stock Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Additional Paid In Capital | 591.17 | 587.94 | 511.63 | 406.55 | 404.11 | |
Retained Earnings Accumulated Deficit | -537.07 | -513.01 | -560.75 | -443.66 | -419.06 | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -0.25 | NA | NA | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 3.20 | 1.97 | 2.04 | 2.22 | 1.68 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -19.80 | -16.12 | -17.95 | -18.77 | -20.18 | |
Net Cash Provided By Used In Investing Activities | -0.14 | -0.01 | -3.49 | 0.05 | -3.90 | |
Net Cash Provided By Used In Financing Activities | -0.02 | -4.25 | 140.63 | 0.38 | -0.37 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -19.80 | -16.12 | -17.95 | -18.77 | -20.18 | |
Net Income Loss | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 | |
Profit Loss | -24.06 | 47.74 | -117.09 | -24.60 | -17.62 | |
Increase Decrease In Accounts Payable | 3.98 | -1.23 | -3.19 | 1.76 | 0.36 | |
Share Based Compensation | 3.20 | 1.97 | 2.04 | 2.22 | 1.68 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | -0.14 | -0.01 | -3.49 | 0.05 | -3.90 | |
Payments To Acquire Property Plant And Equipment | 0.14 | 0.02 | 0.00 | -0.05 | 3.90 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | -0.02 | -4.25 | 140.63 | 0.38 | -0.37 |
2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | ||
---|---|---|---|---|---|---|
Revenues | 3.41 | 3.60 | 4.75 | 2.40 | 4.71 | |
Abeona Rett Agreement | 3.40 | 3.70 | 2.40 | NA | 4.70 | |
Giant Axonal Neuropathy Agreement | NA | 0.00 | 2.30 | NA | NA |